These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 14062839)

  • 1. EXCRETORY PATTERNS AND CLINICAL RESPONSE TO THE TABLET AND PROLONGED-ACTION FORMS OF THIORIDAZINE.
    COHEN S
    Proc West Pharmacol Soc; 1963; 6():65-7. PubMed ID: 14062839
    [No Abstract]   [Full Text] [Related]  

  • 2. SERUM CONCENTRATIONS OF THIORIDAZINE AFTER DIFFERENT ORAL MEDICATION FORMS.
    MELLINGER TJ
    Am J Psychiatry; 1965 May; 121():1119-22. PubMed ID: 14288952
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of thioridazine tablets to chlorpromazine spansules in the maintenance care of chronic schizophrenics.
    Bartlett C
    Curr Ther Res Clin Exp; 1971 Feb; 13(2):100-6. PubMed ID: 4994211
    [No Abstract]   [Full Text] [Related]  

  • 4. THIORIDAZINE BLOOD LEVELS IN PATIENTS RECEIVING DIFFERENT ORAL FORMS.
    MELLINGER TJ; MELLINGER EM; SMITH WT
    Clin Pharmacol Ther; 1965; 6():486-91. PubMed ID: 14314972
    [No Abstract]   [Full Text] [Related]  

  • 5. Compressed collagen sponges as gastroretentive dosage forms: in vitro and in vivo studies.
    Gröning R; Cloer C; Georgarakis M; Müller RS
    Eur J Pharm Sci; 2007 Jan; 30(1):1-6. PubMed ID: 17101267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of prolonged-action medication. II. Two phenothiazine tranquilizers (thioridazine and chlorpromazine) administered as coated tablets and prolongedaction preparations.
    HOLLISTER LE
    Curr Ther Res Clin Exp; 1962 Sep; 4():471-9. PubMed ID: 13908453
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preparation of verapamil hydrochloride core-in-cup tablets with double-pulsatile and multi-phasic release].
    Li CJ; Zhu JB; Yu WY
    Yao Xue Xue Bao; 2008 Jun; 43(6):652-6. PubMed ID: 18822971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. About a non-fatal massive intoxication with sustained-release thioridazine. Clinical and therapeutic problems.
    Buysschaert M; Mahieu P; Hassoun A; Col J; Reynaert M; Tremouroux J
    Acta Pharmacol Toxicol (Copenh); 1977; 41 Suppl 2():153-62. PubMed ID: 302559
    [No Abstract]   [Full Text] [Related]  

  • 10. [On research in urine of normal type and delayed-action type thioridazine by means of the Forrest method].
    Borghesi R; Medaglini E
    Rass Studi Psichiatr; 1965; 54(2):181-4. PubMed ID: 5857473
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the pharmacokinetics of miconazole after administration via a bioadhesive slow release tablet and an oral gel to healthy male and female subjects.
    Cardot JM; Chaumont C; Dubray C; Costantini D; Aiache JM
    Br J Clin Pharmacol; 2004 Oct; 58(4):345-51. PubMed ID: 15373926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation of a extended release tablet containing dexibuprofen.
    Yi HG; Chi MH; Kim YI; Woo JS; Park ES
    Arch Pharm Res; 2008 Dec; 31(12):1637-43. PubMed ID: 19099235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and evaluation of a novel delayed-onset sustained-release system of propranolol hydrochloride.
    Feng XM; Ren Q; Zhang WZ; Shen HF; Rong ZX; Fang C; Chen HZ
    J Pharm Pharmacol; 2008 Jul; 60(7):817-22. PubMed ID: 18549667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical therapeutic trials of the preparation "Melleril-retard"].
    Predescu V; Vianu I; Florescu D
    Neurol Psihiatr Neurochir; 1968; 13(4):289-94. PubMed ID: 5700979
    [No Abstract]   [Full Text] [Related]  

  • 15. [The pharmacokinetics and bioequivalence of acipimox sustained-release tablets after a single and multiple oral administration in healthy dogs].
    Yang XG; Nie SF; Bai HJ; Zhang GJ; Pan WS
    Yao Xue Xue Bao; 2005 May; 40(5):457-61. PubMed ID: 16220793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel compression-coated doughnut-shaped tablet design for zero-order sustained release.
    Sundy E; Danckwerts MP
    Eur J Pharm Sci; 2004 Aug; 22(5):477-85. PubMed ID: 15265518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nervous tension and its treatment with delayed-action Melleril-30].
    Zumkeller RF
    Schweiz Rundsch Med Prax; 1970 Jun; 59(25):943-6. PubMed ID: 5513427
    [No Abstract]   [Full Text] [Related]  

  • 18. Bioavailability of amoxicillin and clavulanic acid from extended release tablets depends on intragastric tablet deposition and gastric emptying.
    Weitschies W; Friedrich C; Wedemeyer RS; Schmidtmann M; Kosch O; Kinzig M; Trahms L; Sörgel F; Siegmund W; Horkovics-Kovats S; Schwarz F; Raneburger J; Mönnikes H
    Eur J Pharm Biopharm; 2008 Oct; 70(2):641-8. PubMed ID: 18582572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium.
    Savaşer A; Ozkan Y; Işimer A
    Farmaco; 2005 Feb; 60(2):171-7. PubMed ID: 15752476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation of intelligent tablets with an antacid effect.
    Bajdik J; Korbely A; Pintye-Hódi K
    Pharm Dev Technol; 2009; 14(5):471-5. PubMed ID: 19552554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.